GENE ONLINE|News &
Opinion
Blog

2017-11-03|

November 3, 1950: American Biochemist James Rothman was Born

by GeneOnline
Share To

James Rothman (November 3, 1950 – present) is an American biochemist. He is the Fergus F. Wallace Professor of Biomedical Sciences at Yale University and the Chairman of the Department of Cell Biology at Yale School of Medicine. Rothman dedicates his career in studying intracellular and extracellular vesicles and the trafficking mechanism. Rothman had a great contribution in discoverying how the sac-like structures within and between cells precisely transport hormones, growth factors, and other molecules to correlated destination. Rothman jointly received the 2013 Nobel Prize in Physiology or Medicine with Randy Schekman and Thomas C. Südhof for their work on vesicle trafficking. He has also received many other honors, including the King Faisal International Prize in 1996, the Louisa Gross Horwitz Prize from Columbia University and the Albert Lasker Award for Basic Medical Research both in 2002.

Reference

https://www.nobelprize.org/nobel_prizes/medicine/laureates/2013/rothman-bio.html https://en.wikipedia.org/wiki/James_Rothman

Image Source

http://fmri.org/commentary/

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Svante Pääbo Wins Physiology or Medicine Nobel Prize for Human Evolution Discoveries
2022-10-06
Three Scientists Jointly Win Nobel Prize for Innovations in Click Chemistry
2022-10-06
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
LATEST
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Amgen Faces Class Action Lawsuit for Concealing $10.7 Billion Tax Bill to Manipulate Stock Price
2023-03-16
ImmunoPrecise Antibodies, Libera Bio Ink $155 Million Pact To Deliver Antibodies With Nanotechnology
2023-03-16
Dermavant Eyes Second Vtama Indication with Topline Atopic Dermatitis Results
2023-03-15
Scroll to Top